Allore Heather G, Murphy Terrence E
Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Clin Trials. 2008;5(2):121-30. doi: 10.1177/1740774508089278.
Many clinical trials are designed to test an intervention arm against a control arm wherein all subjects are equally eligible for all interventional components. Factorial designs have extended this to test multiple intervention components and their interactions. A newer design referred to as a ;standardly-tailored' design, is a multicomponent interventional trial that applies individual interventional components to modify risk factors identified a priori and tests whether health outcomes differ between treatment arms. Standardly-tailored designs do not require that all subjects be eligible for every interventional component. Although standardly-tailored designs yield an estimate for the net effect of the multicomponent intervention, it has not yet been shown if they permit separate, unbiased estimation of individual component effects. The ability to estimate the most potent interventional components has direct bearing on conducting second stage translational research.
We present statistical issues related to the estimation of individual component effects in trials of geriatric conditions using factorial and standardly-tailored designs. The medical community is interested in second stage translational research involving the transfer of results from a randomized clinical trial to a community setting. Before such research is undertaken, main effects and synergistic and or antagonistic interactions between them should be identified. Knowledge of the relative strength and direction of the effects of the individual components and their interactions facilitates the successful transfer of clinically significant findings and may potentially reduce the number of interventional components needed. Therefore the current inability of the standardly-tailored design to provide unbiased estimates of individual interventional components is a serious limitation in their applicability to second stage translational research.
We discuss estimation of individual component effects from the family of factorial designs and this limitation for standardly-tailored designs. We use the phrase ;factorial designs' to describe full-factorial designs and their derivatives including the fractional factorial, partial factorial, incomplete factorial and modified reciprocal designs. We suggest two potential directions for designing multicomponent interventions to facilitate unbiased estimates of individual interventional components.
Full factorial designs and their variants are the most common multicomponent trial design described in the literature and differ meaningfully from standardly-tailored designs. Factorial and standardly-tailored designs result in similar estimates of net effect with different levels of precision. Unbiased estimation of individual component effects from a standardly-tailored design will require new methodology.
Although clinically relevant in geriatrics, previous applications of standardly-tailored designs have not provided unbiased estimates of the effects of individual interventional components.
Future directions to estimate individual component effects from standardly-tailored designs include applying D-optimal designs and creating independent linear combinations of risk factors analogous to factor analysis.
Methods are needed to extract unbiased estimates of the effects of individual interventional components from standardly-tailored designs.
许多临床试验旨在测试干预组与对照组,其中所有受试者均有同等资格接受所有干预措施。析因设计将此扩展到测试多个干预措施及其相互作用。一种称为“标准定制”设计的更新设计是一种多组分干预试验,它应用个体干预措施来改变事先确定的风险因素,并测试各治疗组之间的健康结果是否存在差异。标准定制设计并不要求所有受试者都有资格接受每一项干预措施。虽然标准定制设计能得出多组分干预净效应的估计值,但尚未证明它们是否允许对各个组分效应进行单独、无偏估计。估计最有效的干预组分的能力对开展第二阶段转化研究具有直接影响。
我们提出了在老年病状况试验中使用析因设计和标准定制设计时与估计各个组分效应相关的统计学问题。医学界对涉及将随机临床试验结果转化到社区环境的第二阶段转化研究很感兴趣。在进行此类研究之前,应确定主要效应以及它们之间的协同和/或拮抗相互作用。了解各个组分效应的相对强度和方向及其相互作用有助于成功转化具有临床意义的研究结果,并可能减少所需的干预组分数量。因此,目前标准定制设计无法提供各个干预组分的无偏估计是其应用于第二阶段转化研究的一个严重限制。
我们讨论了析因设计族中各个组分效应的估计以及标准定制设计的这一局限性。我们使用“析因设计”一词来描述全析因设计及其衍生设计,包括分式析因、部分析因、不完全析因和修正互反设计。我们提出了设计多组分干预措施以促进对各个干预组分进行无偏估计的两个潜在方向。
全析因设计及其变体是文献中描述的最常见的多组分试验设计,与标准定制设计有显著差异。析因设计和标准定制设计得出的净效应估计值相似,但精度水平不同。要从标准定制设计中无偏估计各个组分效应,需要新的方法。
尽管在老年医学中具有临床相关性,但标准定制设计以前的应用并未提供各个干预组分效应的无偏估计。
从标准定制设计中估计各个组分效应的未来方向包括应用D - 最优设计以及创建类似于因子分析的风险因素独立线性组合。
需要方法从标准定制设计中提取各个干预组分效应的无偏估计。